Journal article
Current status of the management of symptomatic intracranial atherosclerotic disease: the rationale for a randomized trial of medical therapy and intracranial stenting
Journal of neurointerventional surgery, Vol.1(1), pp.35-39
07/2009
DOI: 10.1136/jnis.2009.000125
PMID: 21994103
Abstract
Stenting and Aggressive Medical Management for Preventing Recurrent stroke in Intracranial Stenosis (SAMMPRIS) is a randomized trial comparing aggressive medical management alone with aggressive medical management in combination with angioplasty and stenting using the Gateway–Wingspan system in patients with symptomatic, high-grade, intracranial stenosis. This trial represents a landmark in the maturation of the field of neurointervention, establishing a foundation for evidenced-based practice. We review the natural history of symptomatic intracranial stenosis when treated medically, the available interventional therapies and the rationale for the design of the SAMMPRIS trial.
Details
- Title: Subtitle
- Current status of the management of symptomatic intracranial atherosclerotic disease: the rationale for a randomized trial of medical therapy and intracranial stenting
- Creators
- D Fiorella - Department of Neurosurgery, Stony Brook University Medical Center, Stony Brook, New York, New York, USAT N Turan - Division of Neurology, Medical University of South Carolina, Charleston, South Carolina, USAC P Derdeyn - Division of Radiology, Neurology and Neurosurgery, Washington University, St. Louis, Missouri, USAM I Chimowitz - Division of Neurology, Medical University of South Carolina, Charleston, South Carolina, USA
- Resource Type
- Journal article
- Publication Details
- Journal of neurointerventional surgery, Vol.1(1), pp.35-39
- DOI
- 10.1136/jnis.2009.000125
- PMID
- 21994103
- ISSN
- 1759-8478
- eISSN
- 1759-8486
- Language
- English
- Date published
- 07/2009
- Academic Unit
- Neurology; Radiology; Iowa Neuroscience Institute; Neurosurgery
- Record Identifier
- 9984020654602771
Metrics
13 Record Views